Now drug-resistant genes can be identified in less than half the time
06 June 2019
Researcher Emily Crawford of Chan Zuckerberg Biohub and UC San Francisco has created a gene-based technology — FLASH — that addresses this problem.
FLASH uses CRISPR/Cas9’s precise gene-targeting ability, plus a couple of classic molecular biology tricks to build a platform to amplify and sequence specific DNA molecules of pathogens with antimicrobial resistant genes.
Further reading: Down to Earth
Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
Ambassador Network
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!
